0/5

Corporate strategy

With the analysis done — the environment mapped, the organisation's capabilities graded — the work shifts from analysis to choice. Strategic choices happen at three distinct levels, each with its own decision-makers, its own question, and its own time horizon.

LevelWho decidesCore questionHorizon
CorporateBoard / group CEOWhich businesses should we be in? How do we allocate capital across them?5–10 years
BusinessDivisional MD / BU headHow do we compete and win within our chosen market?2–5 years
FunctionalFunctional heads (CFO, CMO, COO…)How does each function support the business strategy?1–2 years

Confusing the levels is one of the most common strategy mistakes in practice — corporate leadership meddling in operational decisions, or business units making portfolio choices that belong with the board. This step sits at the top of the hierarchy: corporate-level strategy, the most consequential and the hardest to reverse. Entering a new industry or acquiring a business takes years to undo if it turns out to be wrong, which is why the analytical work had to come first.

The four corporate directions

At the corporate level the fundamental question is what direction the organisation should move in, and there are four broad answers. Every corporate-level decision fits one of them.

DirectionWhat it meansWhen to choose it
GrowthExpand — into new products, markets or businesses; increase revenue and competitive scopeWhen the environment offers real opportunity and the firm has the capability and capital to capture it
StabilityMaintain the current position; protect what works without significant new investmentWhen the market is mature, the firm performs well, and disruption carries more risk than growth
RetrenchmentPull back — cut costs, exit underperformers, refocus on core strengthsWhen performance is declining, resources are stretched, or parts of the portfolio destroy value
CombinationApply different directions to different business units simultaneouslyWhen the portfolio is diverse — some units merit growth, others stability or exit

Most large Zambian organisations are combination strategists without labelling it. Zambeef invests aggressively in cold-chain capacity (growth) while running its retail outlets as mature steady earners (stability). First Quantum expands into new minerals and geographies while exiting mines that no longer cover their cost of capital (retrenchment). In a case answer, resist the urge to stamp one direction on a whole company — read the portfolio unit by unit.

How organisations grow — four paths

Choosing growth still leaves the question of how. The four main growth paths carry very different risk profiles and capability requirements, roughly in rising order of distance from what the firm already knows.

Concentrated growth (intensification) focuses resources on profitable growth within the existing product and existing market. The logic is blunt: if the current market is not fully captured, why look elsewhere? Zambia's mobile money market ran on concentrated growth for years — MTN, Airtel and Zamtel fighting for the same customer base — until saturation pushed them toward new segments.

Market development takes an existing product into a new market — Zambian Breweries pushing distribution into rural areas or neighbouring countries. Product development launches new products for existing customers — a bank adding insurance and pensions for its account holders. Both are lower-risk than full diversification because the firm builds on something it already knows well: either the product or the customer.

  • Vertical integration, backward: expand toward suppliers — Zambeef owning its feedlots, abattoirs and processing plants, controlling every stage from animal to packaged product.
  • Vertical integration, forward: expand toward customers — a manufacturer opening its own retail outlets. Margin capture and direct customer relationships, at the risk that retail needs very different capabilities than manufacturing.
  • Horizontal integration: acquire or merge with a competitor at the same stage of the value chain — Stanbic's acquisition of CFC Bank: same industry, same customers, merged for scale. The recurring risk is that integration costs and culture clashes destroy the value the deal was meant to create.
The growth paths are ordered by distance from what the firm already knows. Each step away — new market, new product, new stage of the chain, new industry — adds risk that must be paid for by a bigger prize.

Diversification — and its three tests

Diversification means entering a business genuinely new to the firm — different products, different markets, different competitive dynamics. It is the highest-risk growth path, and decades of research are humbling: most diversification moves destroy shareholder value. Done well, it can spread income across businesses and create value where real synergies exist — but "real" is the operative word.

Related (concentric) diversification enters businesses that share technology, customers, channels or brand with the core. The test is whether specific synergies exist — named cost savings or revenue gains that would not exist if the businesses were separate, not just the word synergy in a board paper. A Zambian bank entering asset management, insurance or stockbroking is the classic case: same customers, complementary products, shared compliance infrastructure.

Unrelated (conglomerate) diversification enters businesses with no strategic connection to the core. The only rationale is financial — the acquirer believes it can manage the target better than its current owners, or that cash flows from different industries reduce overall risk. It is notoriously hard to execute: running a mining company and a supermarket chain requires entirely different capabilities, and most large conglomerates eventually break up because the parts are worth more separately.

TestThe question
1. Industry attractivenessIs the target industry genuinely attractive, or are you buying into a declining sector?
2. Cost of entryWill you pay so much to get in that future profits can never justify the price?
3. Better-offWill the combined entity be better off than the businesses operating independently?

Every proposed diversification must pass all three. Zambeef's portfolio — beef, chicken, fish, retail, cold-chain logistics — reads as related diversification with genuine synergies: the cold chain and the shops serve every protein line at once. The parts of a portfolio that fail the better-off test are the ones a retrenchment review eventually finds.

The BCG matrix — allocating capital across the portfolio

An organisation running multiple businesses needs a way to decide where to invest, where to harvest, and where to exit. The BCG growth-share matrix maps every business unit on two dimensions — market growth rate and relative market share — producing four quadrants with distinct strategic logic.

QuadrantGrowthShareStrategic logicCash flow
StarsHighHighInvest heavily to hold position; today's stars become tomorrow's cash cows as the market maturesRoughly neutral — earns cash and consumes it
Cash cowsLowHighMilk the profits; don't over-invest; the cash funds the stars and question marksStrongly positive — the portfolio's engine
Question marksHighLowDecide quickly: invest to become a star, or exit before the market matures around youNegative — growth demands investment, low share limits return
DogsLowLowExit or reposition; they consume attention and rarely cover their cost of capitalNeutral to negative

Apply it to Zambian Breweries. Mosi Lager — dominant share of a mature mass market — is the classic cash cow, the earnings engine. Eagle and Rhino, the affordable sorghum beers, sit between cow and star depending on how fast that segment grows. The premium imported brands it distributes — low share of an emerging segment — are question marks: invest seriously in premium positioning, or leave the segment to independents. The matrix's real output is that sentence — a capital-allocation argument per unit.

Use it with its limits in view. The matrix assumes market share drives profitability (through experience-curve effects) and that high-growth markets are always worth entering — neither is universally true. Treat BCG as the starting framework for the portfolio conversation, and let the three diversification tests keep the final say on any entry or exit.

Keep going

0 of 5 sections answered.